Categories: News

Annual financial report 2020

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FINANCIERE DE TUBIZE SA/NV

Allée de la Recherche 60, 1070 Brussels

Contact: Anne Sophie Pijcke, directeur, aspijcke@financiere-tubize.be

Annual financial report 2020

Regulated information
27 February 2021

The board of directors of Financière de Tubize has established the 2020 annual financial report. This report is available on the website www.financiere-tubize.be

  • Dividend received from UCB: € 84,4 million (against € 82.4 million in 2019)
  • Profit of € 81,0 million (against € 80.0 million in 2019)
  • Decrease of outstanding debt from € 86.5 million at 31 December 2019 to € 33,5 million at 31 December 2020.

If the general shareholders meeting of 30 April 2021 approves the 2020 annual accounts, including the proposed result appropriation, a dividend of € 0,68 will be payable as from 6th of May 2021 onwards at the offices, seats and branches of BNP Paribas Fortis, in exchange of coupon n° 16.

Ex-dividend                     4 May 2021
Record date                     4 May 2021
Payment date                  6 May 2021

In addition, the company Other Look SRL (Ol2EF) represented by Mrs Anne-Sophie Pijcke has given its resignation with effect at the end of the Ordinary General Assembly on 30 April 2021. The new Director of the Company will, from that date, be the company ENRE SRL, represented by its director Mr. Eric Nys, whose head office is established Place Obert de Thieusies at 7830 Silly, which will carry out missions similar to those previously devolved to Ol2EF SRL.

Staff

Recent Posts

Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894

To be presented at 11th Annual Immunotherapy of Cancer (ITOC) Conference in Munich, Germany Marlborough,…

25 minutes ago

NervGen Pharma Reports 2024 Year-End Financial Results and Provides Business Updates

Completed enrollment in the chronic cohort and commenced enrollment in the subacute cohort of its…

25 minutes ago

Promino Nutritional Sciences Inc. Reports Q1 2025 Revenue from the Amazon.com Platform

Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC…

1 hour ago

Kanazawa University research: New Breakthrough in Cancer Treatment: Tiny Vesicles Help the Immune System Fight Tumors

KANAZAWA, Japan, April 3, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

2 hours ago

The Pause Technologies Completes Participation in 2025 Mayo Clinic and ASU MedTech Accelerator

SCOTTSDALE, Ariz., April 2, 2025 /PRNewswire/ -- The Pause Technologies, a real-time AI platform dedicated…

8 hours ago

HiTouch, a Mobile App that Improves the Happiness of Individuals and Organizations

SEOUL, South Korea, April 3, 2025 /PRNewswire/ -- As the social atmosphere emphasizes the importance of…

8 hours ago